A randomised comparison of novolimus-eluting and zotarolimus-eluting coronary stents: 9-month follow-up results of the EXCELLA II study.
Serruys PW, Garg S, Abizaid A, Ormiston J, Windecker S, Verheye S, Dubois C, Stewart J, Hauptmann KE, Schofer J, Stangl K, Witzenbichler B, Wiemer M, Barbato E, de Vries T, den Drijver AM, Otake H, Meredith L, Toyloy S, Fitzgerald P.
Serruys PW, et al. Among authors: witzenbichler b.
EuroIntervention. 2010 Jun;6(2):195-205.
EuroIntervention. 2010.
PMID: 20562069
Clinical Trial.